Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,257,087 papers from all fields of science
Search
Sign In
Create Free Account
LY9 gene
Known as:
LY9
, lymphocyte antigen 9
, SLAMF3
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Viral CD229 (Ly9) homologs as new manipulators of host immunity
A. Angulo
,
Marta Cuenca
,
Pablo Martínez-Vicente
,
P. Engel
Journal of Leukocyte Biology
2019
Corpus ID: 73480511
The signaling lymphocytic activation molecule family (SLAMF) of receptors plays crucial roles during innate and adaptive immune…
Expand
2015
2015
CD229 Expression on Bone Marrow Plasma Cells from Patients with Multiple Myeloma and Monoclonal Gammopathies of Uncertain Significance
G. Carulli
,
G. Buda
,
+5 authors
M. Petrini
Acta Haematologica
2015
Corpus ID: 39304582
sponse to therapy, such as VGPR or PR, was assessed according to the criteria of the International Myeloma Working Group [4…
Expand
2014
2014
The Expression of the Hepatocyte SLAMF3 (CD229) Receptor Enhances the Hepatitis C Virus Infection
F. Cartier
,
I. Marcq
,
+5 authors
H. Bouhlal
PLoS ONE
2014
Corpus ID: 1167321
Hepatitis C virus (HCV) is a leading cause of cirrhosis and liver cancer worldwide. We recently characterized for the first time…
Expand
2010
2010
Co‐ordinated regulation of plasmacytoid dendritic cell surface receptors upon stimulation with herpes simplex virus type 1
P. Schuster
,
N. Donhauser
,
+5 authors
B. Schmidt
Immunology
2010
Corpus ID: 10447523
Human plasmacytoid dendritic cells (PDC) are crucial for innate and adaptive immune responses against viral infections, mainly…
Expand
Highly Cited
2006
Highly Cited
2006
Ly9 (CD229)-Deficient Mice Exhibit T Cell Defects yet Do Not Share Several Phenotypic Characteristics Associated with SLAM- and SAP-Deficient Mice1
D. Graham
,
M. Bell
,
+5 authors
D. McKean
Journal of Immunology
2006
Corpus ID: 35574012
Signaling lymphocyte activation molecule (SLAM) family receptors are critically involved in modulating innate and adaptive immune…
Expand
2004
2004
Isolation and characterization of cDNA clones for Humly9: the human homologue of mouse Ly9
M. Sandrin
,
M. Henning
,
Michael F. Lo
,
E. Baker
,
G. Sutherland
,
I. McKenzie
Immunogenetics
2004
Corpus ID: 10045488
Ly9 is a mouse cell membrane antigen found on all lymphocytes and coded for by a gene that maps to chromosome 1. We previously…
Expand
2004
2004
Mouse serum amyloid P-component (SAP) levels controlled by a locus on chromosome 1
R. Mortensen
,
P. Let
,
B. Taylor
Immunogenetics
2004
Corpus ID: 34892059
Recombinant inbred strains were used to demonstrate the existence of a major locus on chromosome 1, designated Sap, which…
Expand
2002
2002
Mouse novel Ly9: a new member of the expanding CD150 (SLAM) family of leukocyte cell-surface receptors
V. Tovar
,
J. D. Del Valle
,
+6 authors
P. Engel
Immunogenetics
2002
Corpus ID: 38277782
Abstract. Human CS1, also known as novel Ly9, 19A24, or CRACC, is a member of the immunoglobulin gene superfamily (IgSF…
Expand
2001
2001
Identification and cloning of an 85-kDa protein homologous to RING3 that is upregulated in proliferating endothelial cells.
RachidaâSiham BelAiba
,
Patrick Baril
,
Yahia Chebloune
,
Eric Tabone
,
Habib Boukerche
European Journal of Biochemistry
2001
Corpus ID: 13141060
A central event in angiogenesis is proliferation of blood vessels, which plays a major role in the progression of a number of…
Expand
2000
2000
Gene structure of the mouse leukocyte cell surface molecule Ly9
V. Tovar
,
M. A. de la Fuente
,
P. Pizcueta
,
J. Bosch
,
P. Engel
Immunogenetics
2000
Corpus ID: 23932012
Abstract. The Ly9 glycoprotein is a member of the immunoglobulin (Ig) superfamily, which is expressed on the cell surface of B…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE